Sedation and tranquilization. A comparison of the effects of a number of psychopharmacologic agents upon normal human subjects.

The introduction of chlorpromazine and reserpine as therapeutic agents has given great impetus to the field of psychopharmacology. The subsequent rapid development of other new drugs has increased the need for improved techniques of assessing drug effects and for investigations of the mechanisms of their action. The diverse and complex actions of these agents has, in addition, resulted in new terminologies and concepts. "Tranquilizer," "psychic normalizer," "ataractic," "neuroleptic," and "psychic energizer" are among the new terms introduced. These new terms have become very popular; many have even

[1]  G. Klerman,et al.  Psycho-physiologic evaluation of phenyltoloxamine, a new phrenotropic agent; a comparative study with reserpine and placebo. , 1958, The American journal of psychiatry.

[2]  A. Wikler.  The Relation of Psychiatry to Pharmacology , 1958 .

[3]  R. Wilkins.  FROM SNAKE ROOT TO SEROTONIN † , 1958, Journal of the American Geriatrics Society.

[4]  E. H. Townsend.  Prolonged cough suppression. , 1958, The New England journal of medicine.

[5]  N. Bigelow,et al.  Affective changes produced by some phenothiazine and diphenyl derivatives in certain psychiatric syndromes. , 1957, Psychiatric research reports.

[6]  A. Dimascio,et al.  A study of the effects of L.S.D.: physiologic and psychological changes and their interrelations. , 1957, American Journal of Psychiatry.

[7]  M. Rinkel.  PHARMACODYNAMICS OF LSD AND MESCALINE , 1957, The Journal of nervous and mental disease.

[8]  G. Kernohan.  Stupor During Reserpine Therapy , 1957 .

[9]  A. Dimascio,et al.  Physiological Correlates of Tension and Antagonism During Psychotherapy: A Study of "Interpersonal Physiology" , 1957, Psychosomatic medicine.

[10]  M. Greenblatt,et al.  Physiological evidence of rapport during psychotherapeutic interviews. , 1956, Diseases of the nervous system.

[11]  W. B. Spriegel.  Reserpine in the Treatment of Neuropsychiatric, Neurological, and Related Clinical Problems. , 1955 .

[12]  Cronk Ga,et al.  Phenyltoloxamine--dosage, toxicity, and clinical application. , 1955 .

[13]  M. Rinkel,et al.  Experimental psychiatry. III. A chemical concept of psychosis. , 1954, Diseases of the nervous system.

[14]  J. A. Schneider,et al.  Pharmacology of Rauwolfia alkaloids, including reserpine. , 1954, Annals of the New York Academy of Sciences.

[15]  L. Lasagna,et al.  The persistence of mental impairment following a hypnotic dose of a barbiturate. , 1953, The Journal of pharmacology and experimental therapeutics.

[16]  N. Rakieten,et al.  Pharmacological properties of a new antihistaminic agent, phenyltoloxamine (Bristamin). , 1953, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[17]  J. Delay,et al.  [Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)]. , 1952, Annales medico-psychologiques.

[18]  H LABORIT,et al.  [A new vegetative stabilizer; 4560 R.P..]. , 1952, La Presse medicale.

[19]  M. Rinkel,et al.  Experimental schizophrenia-like symptoms. , 1952, The American journal of psychiatry.

[20]  M. Brazier,et al.  Physiological performance following a hypnotic dose of a barbiturate. , 1951, The Journal of pharmacology and experimental therapeutics.

[21]  P. Myerson,et al.  Tapping rhythms in neuropsychiatric cases. , 1949, Journal of Nervous and Mental Disease.

[22]  M. Rinkel,et al.  Psychological and physiological effects of intravenous pervitin. , 1948, The American journal of psychiatry.

[23]  F. Freyhan.  Therapeutic implications of differential effects of new phenothiazine compounds. , 1959, American Journal of Psychiatry.

[24]  Beecher Hk.  Relation of drugs to reaction components in subjective responses. , 1958 .

[25]  R. R. Smith,et al.  Alkylaminoalkyl ethers of the benzylphenols. , 1949, Journal of the American Chemical Society.